In vivo microdialysis to measure antibiotic penetration into soft tissue during cardiac surgery.
暂无分享,去创建一个
E. Tschernko | E. Wolner | Markus Müller | B. Mayer-Helm | K. Skhirtladze | D. Hutschala | C. Kinstner
[1] E. Tschernko,et al. Strategies for the determination of cefazolin in plasma and microdialysis samples by short‐end capillary zone electrophoresis , 2003, Electrophoresis.
[2] B. Leavitt,et al. Serum levels of prophylactic cefazolin during cardiopulmonary bypass surgery. , 2002, The Annals of thoracic surgery.
[3] H. Derendorf,et al. Microdialysis. A novel tool for clinical studies of anti-infective agents. , 2001, European journal of clinical pharmacology.
[4] D. Farin,et al. Pharmacokinetics of Vancomycin Administered as Prophylaxis Before Cardiac Surgery , 2000, Therapeutic drug monitoring.
[5] M. Bergeron,et al. Comparative efficacy of teicoplanin and cefazolin for cardiac operation prophylaxis in 3027 patients. The ESPRIT Group. , 2000, The Journal of thoracic and cardiovascular surgery.
[6] M H Samore,et al. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. , 2000, Circulation.
[7] H. Eichler,et al. Surgery and intensive care procedures affect the target site distribution of piperacillin , 2000, Critical care medicine.
[8] G. Marggraf,et al. Mediastinitis after cardiac surgery--epidemiology and current treatment. , 1999, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.
[9] J. Kennedy,et al. Effects of Surgery on the Pharmacokinetic Parameters of Drugs , 1998, Clinical pharmacokinetics.
[10] H. Eichler,et al. Drug Distribution , 1998, Clinical pharmacokinetics.
[11] W. Ghali,et al. Hospital cost of complications associated with coronary artery bypass graft surgery. , 1997, The American journal of cardiology.
[12] R. Bergström,et al. Sternal wound complications--incidence, microbiology and risk factors. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[13] V. Fraser,et al. The epidemiology of chest and leg wound infections following cardiothoracic surgery. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] R. El Oakley,et al. Postoperative mediastinitis: classification and management. , 1996, The Annals of thoracic surgery.
[15] R. Jones,et al. Mediastinitis After Coronary Artery Bypass Graft Surgery: Risk Factors and Long‐Term Survival , 1995, Circulation.
[16] M. Slaughter,et al. A fifteen-year wound surveillance study after coronary artery bypass. , 1993, The Annals of thoracic surgery.
[17] R W Stewart,et al. J. Maxwell Chamberlain memorial paper. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care. , 1990, The Annals of thoracic surgery.
[18] M. Carrier,et al. Methicillin-resistant Staphylococcus aureus infection in a cardiac surgical unit. , 2002, The Journal of thoracic and cardiovascular surgery.
[19] Ryan Dm. Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans , 1993 .